FDA Approves New Class of Non-Opioid Pain Medication

The U.S. Food and Drug Administration (FDA) recently approved a new prescription pain reliever for adults with moderate to severe acute pain. The drug—branded as Journavx®—is the first in a new class of pain meds that will soon be available nationwide.

“This is really exciting news because for the first time in more than 20 years, we’re developing a brand-new class of analgesics,” says Dr. Jason Smith, MD, an interventional pain physiatrist at Atlantic Health.

How does it work?

Dr. Smith explains this groundbreaking non-opioid medication does not affect the brain’s reward center the way opioids do. Instead, it targets selective pain pathways, blocking the sodium channels that stimulate pain.

What conditions does it treat?

This oral medication is currently FDA-approved solely for short-term pain management use. This includes postsurgical pain, trauma, and acute back pain or osteoarthritic injuries, depending on the severity.

Are there side effects?

Although some patients experience side effects, studies show most responses to Journavx® are relatively mild. Adverse reactions can include itching, rash, or muscle spasms, and may be more severe in patients who are sensitive to these issues.

Three existing classes of prescription pain relievers

Prescription-strength Tylenol® (acetaminophen) disrupts pain signals in the body, making it effective for mild to moderate pain. It lower fevers and relieves aches and pains. However, acetaminophen does not reduce inflammation in the body.
Non-steroid anti-inflammatory drugs (NSAIDs) treat mild to moderate pain by blocking certain enzymes (Cox-1 and Cox-2) and producing prostaglandins that decrease pain, inflammation, and swelling.
Opioids act on the brain’s reward centers. Although opioids are strong and effective, they come with a significant risk of addiction, which has fueled an epidemic of dependency and overdose.

“I describe the three classes of pain medications like a radio station,” says Dr. Smith. “Tylenol® turns down the volume. NSAIDS stop the broadcast altogether. Opioids block the broadcast and play music – songs you want to hear again and again.”

Ushering in a new class of pain relievers

According to Dr. Smith, opioids will always be an effective way to treat short-term pain. What’s needed is a safe long-term way to treat moderate to severe pain. This promising new drug class just might be the answer.

“For now, this new medication is being marketed for severe acute pain,” says Dr. Smith. “But at some point, I wouldn't be surprised if it’s extended to manage long-term pain, too. It’s got a lot of potential.”

Is it time to talk to your doctor?

Despite the drug’s limited availability and insurance coverage, Dr. Smith encourages patients to talk with their doctors about pain management options.

“Patients are already hearing about Journavx® and asking questions,” he says. “It’s important to talk with your health care provider about new advancements in health care.”

Find an Orthopedist

Published: April 30, 2025

Patient StoriesA prenatal ultrasound reveals baby’s rare diseaseWhen a prenatal ultrasound revealed that Dana’s baby had a rare disease, an Atlantic Health team of pediatric specialists stepped in. Today, Dana’s two-year-old son is thriving.

Healthy LivingWhat’s the most overlooked nutrient in your diet? FiberAre you eating enough fiber? For most Americans, the answer is no. An Atlantic Health expert explains why this powerful nutrient deserves a larger role in your diet.

Healthy LivingCan ultra-processed foods fit into a healthy diet? The answer may surprise youUltra-processed foods get a bad rap—but do they all deserve it? An Atlantic Health expert shares the ranking system for processed goods, and how to make smarter choices at the grocery store.

Healthy LivingLearn about ESG, a nonsurgical weight loss procedureSee how endoscopic sleeve gastroplasty at Atlantic Health offers a minimally invasive alternative to bariatric surgery and weight loss medication.

News & InnovationCoroFlow: a precise test for unexplained chest painChest pain without an artery blockage is difficult to diagnose so Atlantic Health offers CoroFlow, a detailed test to identify the problem.

Healthy Living7 common myths about HPVIf you think you understand HPV, these facts may surprise you. An Atlantic Health expert clarifies the misconceptions surrounding humanpapillomavirus (HPV).

Press ReleaseAtlantic Health welcomes new system medical director for women’s healthAtlantic Health is pleased to announce the arrival of Melissa Lozano, MD, MA as the new System Medical Director of Women’s Health.

Press ReleaseThree Atlantic Health hospitals named among America’s Best by HealthgradesMorristown Medical Center and Overlook Medical Center are the only two hospitals in New Jersey on the 50 Best list; Chilton Medical Center again among 250 Best

Children's HealthWhy does the Hepatitis B vaccine at birth matter?The virus known as hepatitis B could quietly threaten your child’s health into adulthood. That’s why Atlantic Health pediatricians continue to recommend the hepatitis B birth dose vaccine as the best source of prevention.

Healthy LivingHow to know if you have an underactive thyroid glandFatigue, weight gain and hair loss may seem unrelated, but could all be tied to an underactive thyroid. An Atlantic Health expert explains how a simple blood test can provide the answer.

Recipes Matcha energy smoothieThis five-minute matcha energy smoothie is not only creamy and naturally sweet, but packed with protein, fiber, and antioxidants for an all-day energy boost.

Healthy LivingWhy am I so tired? 6 ways to fight winter fatigueDiscover reasons why you feel more tired during the winter and natural energy booster recommendations from an Atlantic Health family medicine physician.

FDA approves new class of non-opioid pain medication